Synthetic retinoid Am80 suppresses smooth muscle phenotypic modulation and in-stent neointima formation by inhibiting KLF5

Circulation Research

Volumn 97, Issue 11, 2005, Pages 1132-1141

  Fujiu, Katsuhito ^a   Manabe, Ichiro ^a,d   Ishihara, Atsushi ^a   Oishi, Yumiko ^a   Iwata, Hiroshi ^a   Nishimura, Go ^a   Shindo, Takayuki ^a   Maemura, Koji ^a   Kagechika, Hiroyuki ^b   Shudo, Koichi ^c   Nagai, Ryozo ^a,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c Kawasaki   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Phenotypic modulation; Restenosis; Retinoid; Smooth muscle; Stent

Indexed keywords

RETINOIC ACID RECEPTOR ALPHA; RETINOID DERIVATIVE; RETINOID X RECEPTOR ALPHA; SMALL INTERFERING RNA; TAMIBAROTENE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR KLF5; UNCLASSIFIED DRUG; ACTIN; BENZOIC ACID DERIVATIVE; KLF5 PROTEIN, MOUSE; KRUPPEL LIKE FACTOR; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET-DERIVED GROWTH FACTOR A; RETINOIC ACID RECEPTOR; TETRALIN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL INJURY; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE; IN-STENT RESTENOSIS; MALE; NONHUMAN; PDGF A GENE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; STENT; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL MOTION; CELL PROLIFERATION; CELL STRAIN 3T3; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; INTIMA; METABOLISM; MOUSE; PATHOLOGY; RABBIT;

ACTINS; ANIMALS; BENZOATES; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MICE; MUSCLE, SMOOTH, VASCULAR; NIH 3T3 CELLS; PHENOTYPE; PLATELET-DERIVED GROWTH FACTOR; PROMOTER REGIONS (GENETICS); RABBITS; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTOR ALPHA; STENTS; TETRAHYDRONAPHTHALENES; TRANSCRIPTION, GENETIC; TUNICA INTIMA;

EID: 33644675915     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000190613.22565.13     Document Type: Article

References (19)

1. Schwartz RS, Henry TD. Pathophysiology of coronary artery restenosis. Rev Cardiovasc Med. 2002;3:S4-S9.
2. Manabe I, Nagai R. Regulation of smooth muscle phenotype. Curr Atheroscler Rep. 2003;5:214-222.
3. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84:767-801.
4. Shindo T, Manabe I, Fukushima Y, Tobe K, Aizawa K, Miyamoto S, Kawai-Kowase K, Moriyama N, Imai Y, Kawakami H, Nishimatsu H, Ishikawa T, Suzuki T, Morita H, Maemura K, Sata M, Hirata Y, Komukai M, Kagechika H, Kadowaki T, Kurabayashi M, Nagai R. Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med. 2002;8:856-863.
5. Indolfi C, Mongiardo A, Curcio A, Torella D. Molecular mechanisms of in-stent restenosis and approach to therapy with eluting stents. Trends Cardiovasc Med. 2003;13:142-148.
6. Blank RS, Thompson MM, Owens GK. Cell cycle versus density dependence of smooth muscle alpha actin expression in cultured rat aortic smooth muscle cells. J Cell Biol. 1988;107:299-306.
7. Watanabe N, Kurabayashi M, Shimomura Y, Kawai-Kowase K, Hoshino Y, Manabe I, Watanabe M, Aikawa M, Kuro-o M, Suzuki T, Yazaki Y, Nagai R. BTEB2, a Krüppel-like transcription factor, regulates expression of the SMemb/Nonmuscle myosin heavy chain B (SMemb/NMHC-B) gene. Circ Res. 1999;85:182-191.
8. Manabe I, Owens GK. CArG elements control smooth muscle subtype-specific expression of smooth muscle myosin in vivo. J Clin Invest. 2001;107:823-834.
9. Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrad AR, Vlietstra RE, Holmes DR. Restenosis and the proportional neointimal response to coronary artery injury. J Am Coll Cardiol. 1992;19:267-274.
10. Kollum M, Kaiser S, Kinscherf R, Metz J, Kubler W, Hehrlein C. Apoptosis after stent implantation compared with balloon angioplasty in rabbits. Arterioscler Thromb Vasc Biol. 1997;17:2383-2388.
11. Christen T, Verin V, Bochaton-Piallat M-L, Popowski Y, Ramaekers F, Debruyne P, Camenzind E, van Eys G, Gabbiani G. Mechanisms of neointima formation and remodeling in the porcine coronary artery. Circulation. 2001;103:882-888.
12. Raines EW. PDGF and cardiovascular disease. Cytokine Growth Factor Rev. 2004;15:237-254.
13. Oishi Y, Manabe I, Tobe K, Tsushima K, Shindo T, Fujiu K, Nishimura G, Maemura K, Yamauchi T, Kubota N, Suzuki R, Kitamura T, Akira S, Kadowaki T, Nagai R. Krüppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab. 2005;1:27-39.
14. Pendaries V, Verrecchia F, Michel S, Mauviel A. Retinoic acid receptors interfere with the TGF-b/Smad signaling pathway in a ligand-specific manner. Oncogene. 2003;22:8212-8220.
15. Bastien J, Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene. 2004;328:1-16.
16. Miano JM, Berk BC. Retinoids: versatile biological response modifiers of vascular smooth muscle phenotype. Circ Res. 2000;87:355-362.
17. Barstad RM, Hamers MJ, Stephens RW, Sakariassen KS. Retinoic acid reduces induction of monocyte tissue factor and tissue factor/factor VIIa-dependent arterial thrombus formation. Blood. 1995;86:212-218.
18. Wiegman PJ, Barry WL, McPherson JA, McNamara CA, Gimple LW, Sanders JM, Bishop GG, Powers ER, Ragosta M, Owens GK, Sarembock IJ. all-trans-retinoic acid limits restenosis after balloon angioplasty in the focally atherosclerotic rabbit. Arterioscler Thromb Vasc Biol. 2000;20:89-95.
19. Guagliumi G, Farb A, Musumeci G, Valsecchi O, Tespili M, Motta T, Virmani R. Sirolimus-eluting stent implanted in human coronary artery for 16 months. Circulation. 2003;107:1340-1341.